Tag: GALNT12

ICARE Newsletter Fall 2026

National Comprehensive Cancer Network (NCCN) Guidelines Update: Genetic/Familial High-Risk Assessment: Colorectal, Endometrial, Esophageal, and Gastric (Version 1.2026)

The panel set a specific minimal set of genes to test for colorectal, endometrial, and gastric cancer: COLORECTAL CANCER GENES(including genes that predispose to polyps) Additional genes that sometimes get included: ATM, BLM, CHEK2, GALNT12, RNF43, and RPS20. ENDOMETRIAL (UTERINE) CANCER GENES GASTRIC CANCER GENES Test selection and decision to retest including additional genes beyond these …

Continue reading

Permanent link to this article: https://inheritedcancer.net/nlf20262/

ICARE Newsletter Winter 2019

New Genes: GALNT12

A gene called GALNT12 may be yet another inherited colorectal cancer gene,1 as originally suggested by prior studies.2 The current study screened almost 500 colorectal cancer patients and identified 8 rare variants that may be disease causing. The frequency of variants among colorectal cancer patients was much higher than that observed among population-matched healthy controls, …

Continue reading

Permanent link to this article: https://inheritedcancer.net/13nlw2019/

ICARE Newsletter Summer 2016

Practice Guideline Updates for NCCN Genetic/Familial High-Risk Assessment

The National Comprehensive Cancer Network (NCCN) is a network of oncology healthcare providers who work together to develop best practice guidelines for the delivery of cancer care. Given the increasing use of testing for mutations in several inherited cancer genes at one time (called “multi-gene panel testing”), the Breast/Ovarian and Colorectal Panels sought to provide …

Continue reading

Permanent link to this article: https://inheritedcancer.net/2nls2016/